Featured Research

from universities, journals, and other organizations

Modified technique significantly reduces radiation dose delivered during ECG-triggered coronary CTA exams

Date:
March 22, 2010
Source:
American College of Radiology / American Roentgen Ray Society
Summary:
Reduced or no "padding" during ECG-triggered coronary CT angiography results in a substantial reduction in radiation dose without affecting image quality and interpretability, according to a new study.

Reduced or no "padding" during ECG-triggered coronary CT angiography (CTA) results in a substantial reduction in radiation dose without affecting image quality and interpretability, according to a study in the April issue of the American Journal of Roentgenology. ECG-triggered coronary CTA is a common, minimally invasive procedure that is used to evaluate blockages in the coronary arteries.

"During ECG-triggered coronary CTA, there is a mandatory minimum time that the scanner must be on during each heartbeat, and there is typically extra time added before and after this which is referred to as "padding"," said Troy LaBounty, MD, lead author of the study. "By reducing or eliminating "padding" we shorten the scanner "on time" and lower the radiation dose," said LaBounty.

The study was performed at three different sites, including Weill Cornell Medical College in New York, NY; Fairfax Radiology Associates in Fairfax, VA; and the University of British Columbia in Vancouver, Canada. It included 886 patients who underwent ECG-triggered coronary CTA with a padding duration of either 0, 1-99, or 100-150 milliseconds. "Results showed that increased padding was associated with a greater radiation dose (45 percent increase per 100-millisecond increase in padding)," said LaBounty. No difference in image interpretability was seen between the three groups.

"Our data show that use of minimal or no padding can result in reduced radiation dose with preserved image interpretability in examinations of patients with excellent heart rate control," he said.

"Concerns regarding the radiation exposure associated with coronary CTA have resulted in the development of new techniques to reduce radiation dose. Padding duration can be adjusted on a patient by patient basis, and decreased padding should be considered in dose reduction strategies for patients with excellent heart rate control," said LaBounty.


Story Source:

The above story is based on materials provided by American College of Radiology / American Roentgen Ray Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Troy M. LaBounty, Jonathon Leipsic, James K. Min, Brett Heilbron, G. B. John Mancini, Fay Y. Lin, James P. Earls. Effect of Padding Duration on Radiation Dose and Image Interpretation in Prospectively ECG-Triggered Coronary CT Angiography. American Journal of Roentgenology, 2010; 194 (4): 933 DOI: 10.2214/AJR.09.3371

Cite This Page:

American College of Radiology / American Roentgen Ray Society. "Modified technique significantly reduces radiation dose delivered during ECG-triggered coronary CTA exams." ScienceDaily. ScienceDaily, 22 March 2010. <www.sciencedaily.com/releases/2010/03/100322111933.htm>.
American College of Radiology / American Roentgen Ray Society. (2010, March 22). Modified technique significantly reduces radiation dose delivered during ECG-triggered coronary CTA exams. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/03/100322111933.htm
American College of Radiology / American Roentgen Ray Society. "Modified technique significantly reduces radiation dose delivered during ECG-triggered coronary CTA exams." ScienceDaily. www.sciencedaily.com/releases/2010/03/100322111933.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins